Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001078738 | SCV000283626 | benign | Marfan syndrome; Familial thoracic aortic aneurysm and aortic dissection | 2024-01-04 | criteria provided, single submitter | clinical testing | |
Eurofins Ntd Llc |
RCV000726078 | SCV000341788 | uncertain significance | not provided | 2016-05-02 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000297607 | SCV000522930 | likely benign | not specified | 2017-03-08 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Ambry Genetics | RCV001184770 | SCV000738790 | likely benign | Familial thoracic aortic aneurysm and aortic dissection | 2016-04-26 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Color Diagnostics, |
RCV001184770 | SCV001350832 | benign | Familial thoracic aortic aneurysm and aortic dissection | 2018-12-31 | criteria provided, single submitter | clinical testing | |
CHEO Genetics Diagnostic Laboratory, |
RCV001184770 | SCV003838353 | benign | Familial thoracic aortic aneurysm and aortic dissection | 2022-04-14 | criteria provided, single submitter | clinical testing |